Prostate cancer radiation: a deep dive into the Body's response
NCT ID NCT06200974
First seen Feb 02, 2026 · Last updated May 21, 2026 · Updated 14 times
Summary
This study is for 100 men with low-risk or early intermediate-risk prostate cancer who will receive a type of radiation called HDR brachytherapy. Researchers will use advanced lab tests to see how the radiation changes the cancer's chemistry and the body's immune response. The goal is to learn the best radiation dose and understand how the treatment works, not to test a new cure.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for LOCALIZED PROSTATE CARCINOMA are added.
Genom att skicka in godkänner du våra Användarvillkor
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
Genom att skicka in godkänner du våra Användarvillkor
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
British Columbia Cancer Center for the Southern Interior
RECRUITINGKelowna, British Columbia, V1Y 5L3, Canada
Contact
Contact
Contact Phone: •••-•••-•••• Email: •••••@•••••
Conditions
Explore the condition pages connected to this study.